Statement Of Financial Position [Abstract]

Biocartis Group NV - Filing #3123157

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	37,192,000 EUR	—	—	—	—	—	—	—	—	—	—	40,098,000 EUR	—	—	—	—	—	—	—
Intangible assets other than goodwill	—	—	5,067,000 EUR	—	—	—	—	—	—	—	—	—	—	5,645,000 EUR	—	—	—	—	—	—	—
Deferred tax assets	—	—	1,595,000 EUR	—	—	—	—	—	—	—	—	—	—	1,472,000 EUR	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	53,522,000 EUR	—	—	—	—	—	—	—	—	—	—	123,668,000 EUR	—	—	178,725,000 EUR	—	—	—	—
Assets	—	—	142,480,000 EUR	—	—	—	—	—	—	—	—	—	—	210,517,000 EUR	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	220,657,000 EUR	—	—	—	—	—	—	—	—	—	—	220,657,000 EUR	—	—	—	—	—	—	—
Retained earnings	—	—	526,405,000 EUR	—	—	—	—	—	—	—	—	—	—	455,343,000 EUR	—	—	—	—	—	—	—
Share premium	—	—	711,874,000 EUR	—	—	—	—	—	—	—	—	—	—	711,874,000 EUR	—	—	—	—	—	—	—
Equity	526,405,000 EUR	5,572,000 EUR	33,897,000 EUR	33,897,000 EUR	711,874,000 EUR	6,862,000 EUR	220,657,000 EUR	455,343,000 EUR	36,824,000 EUR	220,657,000 EUR	5,153,000 EUR	711,874,000 EUR	6,102,000 EUR	36,824,000 EUR	84,480,000 EUR	5,291,000 EUR	84,480,000 EUR	698,027,000 EUR	392,259,000 EUR	4,670,000 EUR	220,668,000 EUR
Liabilities [abstract]
Trade and other payables	—	—	11,560,000 EUR	—	—	—	—	—	—	—	—	—	—	13,907,000 EUR	—	—	—	—	—	—	—
Provisions [abstract]
Provisions	—	—	75,000 EUR	—	—	—	—	—	—	—	—	—	—	0 EUR	—	—	—	—	—	—	—
Equity and liabilities	—	—	142,480,000 EUR	—	—	—	—	—	—	—	—	—	—	210,517,000 EUR	—	—	—	—	—	—	—